Events

Booster Info Session: free guidance for EU-funded research results
APR
Tue
01
11:00 - 12:00

This was 2 months ago

Location

Online

Programmes
Horizon Europe

The European Commission and the EU-funded Booster initiative are organising an info session dedicated to Booster. Booster offers free-of-charge services to support EU-funded projects in their journey from results to impact.

During the info session, participants will get a global overview of the services offered by Booster, more information about the expert guidance that can be expected and how services are delivered. The session also includes a Q&A session.

There will be a live stream available on youtube for this online session. Interested to participate? Register here

More information, the detailed agenda and registration on the dedicated Commission webpage

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.